Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension

Shannon Blalock, Frandics Chan, David Rosenthal, Michelle Ogawa, Dawn Maxey, Jeffrey Feinstein

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pulmonary arterial hypertension (PAH) causes changes in the right ventricle (RV), affecting RV size and function, ultimately leading to death. These changes have been evaluated by cardiac MRI (CMR) in adults with PAH, but not in children. Using CMR in pediatric patients with PAH, we examined how RV size and function (1) compare to normal data, (2) change over time, and (3) compare to similar studies in the adult population. Data from two institutions were retrospectively reviewed. Subjects with PAH and a CMR were included. Baseline CMR variables (right and left ventricular end-diastolic and end-systolic volumes indexed for body surface area, and calculated stroke volume and ejection fraction) were compared to normative data and follow-up CMR data. Twenty-six subjects (15 female), age 2-16 (mean 11) years, with idiopathic PAH were included. All patients were on PAH medication, and 65% on prostacyclin therapy. The baseline 6-Minute Walk Distance (6MWD; 481 ± 137) was normal. RV volumes and ejection fraction were markedly abnormal compared to normal data (P < 0.001). Follow-up CMRs were analyzed in 15 patients. RV volumes and function and LV stroke volume showed no significant change over one year. Our pediatric patients with PAH have markedly abnormal right ventricles by CMR but have normal walk distances. The lack of change in CMR parameters over one year may represent a stable cohort and is different than similar studies in adults.

Original languageEnglish (US)
Pages (from-to)350-355
Number of pages6
JournalPulmonary Circulation
Volume3
Issue number2
DOIs
StatePublished - Apr 1 2013

Fingerprint

Pulmonary Hypertension
Heart Ventricles
Magnetic Resonance Imaging
Pediatrics
Stroke Volume
Body Surface Area
Epoprostenol
Population

Keywords

  • Cardiac magnetic resonance
  • Pediatrics
  • Pulmonary hypertension
  • Right ventricle

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension. / Blalock, Shannon; Chan, Frandics; Rosenthal, David; Ogawa, Michelle; Maxey, Dawn; Feinstein, Jeffrey.

In: Pulmonary Circulation, Vol. 3, No. 2, 01.04.2013, p. 350-355.

Research output: Contribution to journalArticle

Blalock, S, Chan, F, Rosenthal, D, Ogawa, M, Maxey, D & Feinstein, J 2013, 'Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension', Pulmonary Circulation, vol. 3, no. 2, pp. 350-355. https://doi.org/10.4103/2045-8932.114763
Blalock, Shannon ; Chan, Frandics ; Rosenthal, David ; Ogawa, Michelle ; Maxey, Dawn ; Feinstein, Jeffrey. / Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension. In: Pulmonary Circulation. 2013 ; Vol. 3, No. 2. pp. 350-355.
@article{e006fc0862134b27ad5d15fb375341b3,
title = "Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension",
abstract = "Pulmonary arterial hypertension (PAH) causes changes in the right ventricle (RV), affecting RV size and function, ultimately leading to death. These changes have been evaluated by cardiac MRI (CMR) in adults with PAH, but not in children. Using CMR in pediatric patients with PAH, we examined how RV size and function (1) compare to normal data, (2) change over time, and (3) compare to similar studies in the adult population. Data from two institutions were retrospectively reviewed. Subjects with PAH and a CMR were included. Baseline CMR variables (right and left ventricular end-diastolic and end-systolic volumes indexed for body surface area, and calculated stroke volume and ejection fraction) were compared to normative data and follow-up CMR data. Twenty-six subjects (15 female), age 2-16 (mean 11) years, with idiopathic PAH were included. All patients were on PAH medication, and 65{\%} on prostacyclin therapy. The baseline 6-Minute Walk Distance (6MWD; 481 ± 137) was normal. RV volumes and ejection fraction were markedly abnormal compared to normal data (P < 0.001). Follow-up CMRs were analyzed in 15 patients. RV volumes and function and LV stroke volume showed no significant change over one year. Our pediatric patients with PAH have markedly abnormal right ventricles by CMR but have normal walk distances. The lack of change in CMR parameters over one year may represent a stable cohort and is different than similar studies in adults.",
keywords = "Cardiac magnetic resonance, Pediatrics, Pulmonary hypertension, Right ventricle",
author = "Shannon Blalock and Frandics Chan and David Rosenthal and Michelle Ogawa and Dawn Maxey and Jeffrey Feinstein",
year = "2013",
month = "4",
day = "1",
doi = "10.4103/2045-8932.114763",
language = "English (US)",
volume = "3",
pages = "350--355",
journal = "Pulmonary Circulation",
issn = "2045-8932",
publisher = "University of Chicago Press",
number = "2",

}

TY - JOUR

T1 - Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension

AU - Blalock, Shannon

AU - Chan, Frandics

AU - Rosenthal, David

AU - Ogawa, Michelle

AU - Maxey, Dawn

AU - Feinstein, Jeffrey

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Pulmonary arterial hypertension (PAH) causes changes in the right ventricle (RV), affecting RV size and function, ultimately leading to death. These changes have been evaluated by cardiac MRI (CMR) in adults with PAH, but not in children. Using CMR in pediatric patients with PAH, we examined how RV size and function (1) compare to normal data, (2) change over time, and (3) compare to similar studies in the adult population. Data from two institutions were retrospectively reviewed. Subjects with PAH and a CMR were included. Baseline CMR variables (right and left ventricular end-diastolic and end-systolic volumes indexed for body surface area, and calculated stroke volume and ejection fraction) were compared to normative data and follow-up CMR data. Twenty-six subjects (15 female), age 2-16 (mean 11) years, with idiopathic PAH were included. All patients were on PAH medication, and 65% on prostacyclin therapy. The baseline 6-Minute Walk Distance (6MWD; 481 ± 137) was normal. RV volumes and ejection fraction were markedly abnormal compared to normal data (P < 0.001). Follow-up CMRs were analyzed in 15 patients. RV volumes and function and LV stroke volume showed no significant change over one year. Our pediatric patients with PAH have markedly abnormal right ventricles by CMR but have normal walk distances. The lack of change in CMR parameters over one year may represent a stable cohort and is different than similar studies in adults.

AB - Pulmonary arterial hypertension (PAH) causes changes in the right ventricle (RV), affecting RV size and function, ultimately leading to death. These changes have been evaluated by cardiac MRI (CMR) in adults with PAH, but not in children. Using CMR in pediatric patients with PAH, we examined how RV size and function (1) compare to normal data, (2) change over time, and (3) compare to similar studies in the adult population. Data from two institutions were retrospectively reviewed. Subjects with PAH and a CMR were included. Baseline CMR variables (right and left ventricular end-diastolic and end-systolic volumes indexed for body surface area, and calculated stroke volume and ejection fraction) were compared to normative data and follow-up CMR data. Twenty-six subjects (15 female), age 2-16 (mean 11) years, with idiopathic PAH were included. All patients were on PAH medication, and 65% on prostacyclin therapy. The baseline 6-Minute Walk Distance (6MWD; 481 ± 137) was normal. RV volumes and ejection fraction were markedly abnormal compared to normal data (P < 0.001). Follow-up CMRs were analyzed in 15 patients. RV volumes and function and LV stroke volume showed no significant change over one year. Our pediatric patients with PAH have markedly abnormal right ventricles by CMR but have normal walk distances. The lack of change in CMR parameters over one year may represent a stable cohort and is different than similar studies in adults.

KW - Cardiac magnetic resonance

KW - Pediatrics

KW - Pulmonary hypertension

KW - Right ventricle

UR - http://www.scopus.com/inward/record.url?scp=84923093150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923093150&partnerID=8YFLogxK

U2 - 10.4103/2045-8932.114763

DO - 10.4103/2045-8932.114763

M3 - Article

C2 - 24015335

AN - SCOPUS:84923093150

VL - 3

SP - 350

EP - 355

JO - Pulmonary Circulation

JF - Pulmonary Circulation

SN - 2045-8932

IS - 2

ER -